OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

Search Results

Your search returned 9 results.
Search:

SKU Category Vector Description Price Delivery
SC323178 Human cDNA pCMV6-XL5 MARK3 (untagged)-Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 4 (10ug) NM_001128920.1 $1290 Immediate
RC226107 Human ORF PS100001 MARK3 (Myc-DDK-tagged)-Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 4 $1030 5-6 weeks
RC226107L1 Human ORF PS100064 Lenti-ORF clone of MARK3 (Myc-DDK-tagged)-Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 4, (10ug) $1400 7-8 weeks
RC226107L2 Human ORF PS100071 Lenti-ORF clone of MARK3 (mGFP-tagged)-Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 4, (10ug) $1540 7-8 weeks
RG226107 Human ORF PS100010 MARK3 (GFP-tagged) - Human MAP/microtubule affinity-regulating kinase 3 (MARK3), transcript variant 4 $1130 5-6 weeks
TF320413 Human shRNA pRFP-C-RS MARK3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector $498 In Stock
TG320413 Human shRNA pGFP-V-RS MARK3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector $650 7-9 Days
TR320413 Human shRNA pRS MARK3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector $650 7-9 Days
/ UTR pMirTarget 3`UTR clone of MAP/microtubule affinity-regulating kinase 3 (MARK3) transcript variant 4 for miRNA target validation NM_001128920.1 $495 3-4 weeks
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title